References

• 2001The Oxytocin Receptor System: Structure, Function, and Regulation3,086 cited
• 2018The Oxytocin Receptor: From Intracellular Signaling to Behavior997 cited
• 2012Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics421 cited
• 2012Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems407 cited
• 2020Is Oxytocin “Nature’s Medicine”?391 cited
• 2006Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications319 cited
• 2020Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research263 cited
• 1988125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT: a selective oxytocin receptor ligand244 cited
• 2002Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist211 cited
• 2011Oxytocin Revisited: Its Role in Cardiovascular Regulation207 cited
• 2022Oxytocin, Vasopressin, and Social Behavior: From Neural Circuits to Clinical Opportunities191 cited
• 2017Oxytocin Receptors in the Anteromedial Bed Nucleus of the Stria Terminalis Promote Stress-Induced Social Avoidance in Female California Mice181 cited
• 2017Oxytocin enhances observational fear in mice